Bruno Constantin

Affiliations: 
Université de Poitiers. UFR des sciences fondamentales et appliquées 
Area:
, Duchenne muscular dystrophy, Calcium, Α1-syntrophin, Human myotubes
Google:
"Bruno Constantin"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Shoji KF, Bayet E, Leverrier-Penna S, et al. (2023) The mechanosensitive TRPV2 calcium channel promotes human melanoma invasiveness and metastatic potential. Embo Reports. e55069
Terrié E, Déliot N, Benzidane Y, et al. (2021) Store-Operated Calcium Channels Control Proliferation and Self-Renewal of Cancer Stem Cells from Glioblastoma. Cancers. 13
Terrié E, Coronas V, Constantin B. (2019) Role of the calcium toolkit in cancer stem cells. Cell Calcium. 80: 141-151
Cabanas H, Harnois T, Magaud C, et al. (2018) Deregulation of calcium homeostasis in Bcr-Abl-dependent chronic myeloid leukemia. Oncotarget. 9: 26309-26327
Domenichini F, Terrié E, Arnault P, et al. (2018) Store-operated Calcium Entries Control Neural Stem Cell Self-renewal in the Adult Brain Subventricular Zone. Stem Cells (Dayton, Ohio)
Fourbon Y, Guéguinou M, Félix R, et al. (2017) Ca(2+) protein alpha 1D of CaV1.3 regulates intracellular calcium concentration and migration of colon cancer cells through a non-canonical activity. Scientific Reports. 7: 14199
Mignen O, Constantin B, Potier-Cartereau M, et al. (2017) Constitutive calcium entry and cancer: updated views and insights. European Biophysics Journal : Ebj
Aguettaz E, Lopez JJ, Krzesiak A, et al. (2016) Data on calcium increases depending on stretch in dystrophic cardiomyocytes. Data in Brief. 8: 1443-7
Constantin B. (2016) Role of Scaffolding Proteins in the Regulation of TRPC-Dependent Calcium Entry. Advances in Experimental Medicine and Biology. 898: 379-403
Guéguinou M, Harnois T, Crottes D, et al. (2016) SK3/TRPC1/Orai1 complex regulates SOCE-dependent colon cancer cell migration: a novel opportunity to modulate anti-EGFR mAb action by the alkyl-lipid Ohmline. Oncotarget
See more...